Differential diagnosis and evaluation of the clinical course of transurethrally resected T1G3 urothelial carcinoma of the bladder by DNA image cytometry

Anticancer Research

Volumn 25, Issue 5, 2005, Pages 3243-3249

  Biesterfeld, S ^a,b   Borchers, H ^b   Jellouschek, H ^b   Bono, A V ^c   Altwein, J E ^d   Algaba, F ^e   Jakse, G ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c UNIVERSITY OF VERONA   (Italy)

^d Hospital Barmherzige Brüder   (Germany)

^e UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Bladder neoplasms; DNA cytometry; Image analysis; Survival analysis

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CONTROLLED STUDY; CYTOMETRY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DNA CONTENT; DNA DETERMINATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; TRANSURETHRAL RESECTION;

AGED; DIAGNOSIS, DIFFERENTIAL; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FEMALE; HUMANS; IMAGE CYTOMETRY; MALE; PLOIDIES; URINARY BLADDER NEOPLASMS;

EID: 23344443364     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Patard JJ, Moudouni S, Saint F, Rioux-Leclercq N, Manunta A, Guy L, Ballanger P, Lanson Y, Hajri M, Irani J, Guillé F, Beurton D, Lobel B and the Members of the Group Necker: Tumor progression and survival in patients with T1G3 bladder tumors: multicentric retrospective study comparing 94 patients treated during 17 years. Urology 58: 551-556, 2001.
2. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD and Hawkins IR: Superficial bladder cancer, progression and recurrence. J Urol 130: 1083-1086, 1983.
3. Thalmann GN, Markwalder R, Shahin O, Burkhard FC, Hochreiter WW and Studer UE: Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy? J Urol 172: 70-75, 2004.
4. Jakse G, Loidl W, Seeber G and Hofstädter F: Stage TI, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor? J Urol 137: 39-43, 1987.
5. Pansadoro V, Emiliozzi P, de Paula F, Scarpone P, Pansadoro A and Sternberg CN: Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guérin: 18-year experience. Urology 59: 227-231, 2002.
6. Herr H and Jakse G: pT1 bladder cancer. Eur Urol 20: 1-8, 1991.
7. Bono AV, Lovisolo JA and Saredi G: Transurethral resection and sequential chemo-immunoprophylaxis in primary T1G3 bladder cancer. Eur Urol 37: 478-483, 2000.
8. Schulte EK, Joos U, Kasper M and Eckert HM: Cytological detection of epithelial dysplasia in the oral mucosa using Feulgen DNA-image cytometry. Diagn Cytopathol 7: 436-441, 1991.
9. Crissman JD and Zarbo RJ: Quantitation of DNA ploidy in squamous intraepithelial neoplasia of the laryngeal glottis. Arch Otolaryngol Head Neck Surg 117: 182-188, 1991.
10. Auffermann W and Böcking A: Early detection of precancerous lesions in dysplasias of the lung by rapid DNA image cytometry. Anal Quant Cytol Histol 7: 218-226, 1985.
11. Evans AS, Monaghan JM and Anderson MC: A nuclear deoxyribonucleic acid analysis of normal and abnormal vulvar epithelium. Obstetr Gynecol 69: 790-793, 1987.
12. Böcking A, Hilgarth M, Auffermann W, Hack-Werdier C, Fischer-Becker D and von Kalckreuth G: DNA cytometric diagnosis of prospective malignancy in borderline lesions of the uterine cervix. Acta Cytol 30: 608-615, 1986.
13. Chatelain R, Schunck T, Schindler E, Schindler A and Böcking A: Diagnosis of prospective malignancy in koilocytic dysplasias of the uterine cervix with DNA cytometry. J Reprod Med 34: 505-510, 1989.
14. Biesterfeld S, Pennings K, Grußendorf-Conen EI and Böcking A: Aneuploidy in actinic keratosis and Bowen's disease - increased risk for invasive squamous cell carcinoma? Br J Dermatol 133: 557-560, 1995.
15. Nasiell K, Auer G, Nasiell M and Zetterberg A: Retrospective DNA analysis in cervical dysplasias as related to neoplastic progression or regression. Anal Quant Cytol 1: 103-106, 1979.
16. Böcking A, Biesterfeld S and Liu SQ: DNA distribution in gastric cancer and dysplasia. In: Zhang YC, Kawai K (eds.): Precancerous Conditions and Lesions of the Stomach, Springer, Berlin, pp. 103-120, 1993.
17. Biesterfeld S, Leitloff M, Rath W and Schröder W: DNA image cytometry in the differential diagnosis of endometrial hyperplasia and endometrial adenocarcinoma. Anal Quant Cytol Histol 23: 123-128, 2001.
18. Biesterfeld S, Reus K, Bayer-Pietsch E, Mihalcea AM and Booking A: DNA image cytometry in the differential diagnosis of endocervical adenocarcinoma. Cancer (Cytopathology) 93: 160-164, 2001.
19. Baak JPA, Bol MGW, van Diermen B, Janssen EAM, Buhr-Wildhagen SB, Mestad O, Øgreid P and Kjellevold KH: DNA cytometric features in biopsies of TaT1 urothelial cell cancer predict recurrence and stage progression more accurately than stage, grade, or treatment modality. Urology 61: 1266-1272, 2003.
20. Desgrippes A, Izadifar V, Assailly J, Fontaine E and Beurton D: Diagnosis and prediction of recurrence and progression in superficial bladder cancers with DNA image cytometry and urinary cytology. Br J Urol 55: 434-436, 2000.
21. Dalquen P, Kleiber B, Grilli B, Herzog M, Bubendorf L and Oberholzer M: DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine. Cancer 96: 374-379, 2002.
22. Delgado R, Mikuz G and Hofstädter F: DNA-Feulgen-cytophotometric analysis of single cells from paraffin embedded tissue. Path Res Pract 179: 92-94, 1984.
23. Hedley DW, Friedlander ML and Taylor IW: Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clincal significance. Cytometry 6: 327-333, 1985.
24. Chatelain R, Willms A, Biesterfeld S, Auffermann W and Böcking A: Automated Feulgen staining with a temperature-controlled machine. Anal Quant Cytol Histol 11: 211-219, 1989.
25. Müller HW, Böcking A and Auer H: TV cytometer CM-1 for computer aided tumor diagnosis. In: Wied GL, Bartels PH, Rosenthal DL, Schenck U (eds.): Compendium of the Computerized Cytologic and Histologic Laboratory. Tutorials of Cytology, Chicago, USA, pp. 376-388, 1994.
26. Haroske G, Giroud F, Reith A and Böcking A: 1997 ESACP consensus report on diagnostic image cytometry. Part I: Basic considerations and recommendations for preparation, measurement and interpretation. Anal Cellul Pathol 17: 189-200, 1998.
27. Motherby H, Marcy T, Hecker M, Ross B, Nadjari B, Auer H, Müller KM, Häussinger D, Strauer BE and Böoking A: Static DNA cytometry as a diagnostic aid in effusion cytology: I. DNA aneuploidy for identification and differentiation of primary and secondary tumors of the serous membranes. Anal Quant Cytol Histol 20: 153-161, 1998.
28. Böcking A, Adler CP, Common HH, Hilgarth M, Granzen B and Auffermann W: Algorithm for a DNA-cytophotometric diagnosis and grading of malignancy. Anal Quant Cytol 6: 1-8, 1984.
29. Ploem-Zaijer JJ, Beyer-Boon ME, Leyte-Veldstra L and Ploem JS: Cytofluorometric and cytophotometric DNA measurements of cervical smears stained using a new bicolor method. In: Pressman NJ, Wied GL (eds.): Automation of Cancer Cytology and Cell Image Analysis. Tutorials of Cytology, Chicago, pp. 225-235, 1979.
30. Chatelain R, Schunck T, Schindler E, Schindler A and Böcking A: Diagnosis of prospective malignancy in koilocytic dysplasias of the uterine cervix with DNA cytometry. J Reprod Med 34: 505-510, 1989.
31. Stenkvist B and Strande G: Entropy as an algorithm for the statistical description of DNA cytometric data obtained by image analysis microscopy. Anal Cellul Pathol 2: 159-165, 1990.
32. Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
33. Lebret T, Becette V, Hervé JM, Molinié V, Barré P, Lugagne PM, Gentille A, Baglin AC and Botto H: Prognostic value of MIB-1 antibody labeling index to predict response to bacillus Calmette-Guérin therapy in a high-risk selected population of patients with stage T1 grade G3 bladder cancer. Eur Urol 37: 654-659, 2000.
34. Peyromaure M, Weibing S, Sehe P, Verpillat P, Toublanc M, Dauge MC, Boccon-Gibod L and Ravery V: Prognostic value of p53 overexpression in T1G3 bladder tumors treated with bacillus Calmette-Guérin therapy. Urology 59: 409-413, 2002.